PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--SDI, the leading provider of de-identified patient-level data analytics and related solutions across the healthcare continuum, announced today an ongoing program that will offer several academic data research grants. The grants will offer full-time faculty members from colleges, universities, teaching hospitals and other research facilities healthcare data to perform retrospective studies and evaluate key healthcare questions. SDI will provide access to its longitudinal prescription data; medical claims data; or, alternatively, its market research audit trend data that reports on the diagnosis and treatment of patients and contributing factors.
“Our hope is that having access to data that is not often available in the public domain will allow researchers to develop novel approaches to research that will ultimately contribute to the ability of healthcare providers to offer higher-quality healthcare,” said Andrew Kress, Chief Executive Officer of SDI. “We are excited about the caliber of work we will see from the grant recipients.”
Applications for the grants will be accepted until August 15, 2011, through SDI’s website at www.sdihealth.com/grants. Grant recipients will be notified by September 15, 2011. For complete grant details, including terms and conditions, please visit www.sdihealth.com/grants.
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, retail pharmacy, and medical device companies, enabling them to better understand the healthcare market. SDI also serves the government and the financial services, media, and consumer packaged goods industries. SDI counts the world’s top 50 pharmaceutical and biotech firms as its clients.